ArticleThe Lancet regional health. Europe2023

Real-life comparison of mortality in patients with SARS-CoV-2 infection at risk for clinical progression treated with molnupiravir or nirmatrelvir plus ritonavir during the Omicron era in Italy: a nationwide, cohort study.

Carlo Torti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.